Industry snapshot
Key public data points
Historical & forecast
Base year 2023. Each series is official through its own latest government-data year (shown in the legend on each chart), and years beyond that are Claight estimates. As of July 2026 the current year is still in progress (2026 annual data is not yet published), so the forecast runs to 2028.
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Industry Definition and Scope
What does the Veterinary Laboratory Testing Services in European Union industry cover?
The veterinary laboratory testing services industry in the EU encompasses clinical-pathological, biochemical, hematological, immunological, and other diagnostic activities pertaining directly to animal health. It supports disease prevention, monitoring, and therapeutic diagnostics across companion animals, equine species, and agricultural livestock.
- •Classified under the official NACE Rev. 2 system under code 75.00 ('Veterinary activities'), which explicitly encompasses clinico-pathological and other diagnostic activities for animals.
- •Services are split between centralized reference laboratories, third-party public health labs, and specialized in-house point-of-care diagnostics conducted at local clinics.
- •Includes diagnostic testing for zoonotic and infectious diseases to prevent massive livestock epidemics across European agricultural chains.
Market Structure and Operators
Who operates in the industry and how is it structured?
The market structure of the European veterinary diagnostics space is divided between highly consolidated multinational reference laboratory networks and highly fragmented local veterinary micro-enterprises. While corporate laboratory groups manage high-volume, complex testing, local diagnostic services are typically executed within veterinary clinics, which are predominantly micro-enterprises.
- •According to Eurostat, approximately 96% of all veterinary enterprises across the EU are micro-enterprises employing fewer than 10 people.
- •Despite the high volume of micro-scale practices, corporate veterinary consolidation (corporatisation) is rapidly concentrating the procurement of laboratory services.
- •Over 70,000 distinct veterinary practices operate in the Union, providing direct channels for rapid in-clinic diagnostic kit distribution.
Demand Drivers
What drives demand in the industry?
Demand is heavily driven by structural growth in companion animal ownership and rising consumer willingness to pay for advanced medical procedures. Additionally, stringent European livestock biosecurity mandates require ongoing diagnostic screening of production animals.
- •There are approximately 91 million pet-owning households in Europe, representing about 46% of all EU households.
- •The expansion of pet health insurance across member states reduces price sensitivity and directly increases the rate of diagnostic lab testing per clinic visit.
- •Ongoing animal welfare and infectious disease surveillance programs track millions of agricultural animals, including 75 million bovines and 134 million pigs.
Competitive Landscape and Notable Public Companies
Who are the notable companies in the industry?
The competitive space consists of major global diagnostic technology providers, specialized corporate veterinary clinic chains, and clinical laboratory giants. These operators compete heavily on turnaround times, diagnostic accuracy, and digital software integration with practice management systems.
- •IDEXX Laboratories, Inc. is a major reference laboratory operator in Europe, managing highly integrated regional diagnostic labs.
- •Zoetis Inc. operates as a leading animal health company providing point-of-care diagnostic equipment and reference lab services.
- •Heska Corporation (acquired by Antech Diagnostics/Mars, Incorporated) maintains a major diagnostic footprint across European clinics.
- •Eurofins Scientific SE, through its specialized Eurofins Technologies and Eurofins Genomics divisions, provides diagnostic kits and testing services for veterinary pathogens.
Recent Trends and Outlook
What are the recent trends and outlook?
Recent trends are defined by the convergence of digital technology and on-site testing capabilities. Clinics are increasingly adopting artificial intelligence (AI) and cloud-connected hematology and chemistry analyzers to obtain instant, reference-lab-quality results in-house.
- •Rising integration of AI-enabled point-of-care diagnostic systems allows real-time slide-free pathology reading within local European clinics.
- •A strong industry shift toward preventative diagnostic panels, which screen healthy older pets for early renal, liver, and metabolic diseases.
- •Increased focus on companion animal therapeutic antibody and immunology diagnostics following regional biotech acquisitions by major animal health firms.
Regulation and Compliance
How is the industry regulated?
The regulatory landscape is governed by both EU-level agricultural directives and strict national-level veterinary medical boards. Diagnostic labs must adhere to stringent quality assurance guidelines, waste management controls, and infectious disease notification protocols.
- •The EU Animal Health Law (Regulation (EU) 2016/429) coordinates national surveillance systems and sets strict frameworks for reporting transmissible animal diseases.
- •Laboratories must comply with ISO/IEC 17025 standards for testing and calibration laboratories to ensure the scientific validity of diagnostic results.
- •Regional veterinary licensing bodies regulate the delegation of lab tasks from registered veterinarians to clinical technicians or laboratory assistants.
Sources
Government, statistical and trade sources used for this Claight analysis.
- Eurostat Statistical Classification of Economic Activities (NACE Rev. 2) 2006/2023 ·
- AnimalhealthEurope Facts and Figures 2022 Report ·
- ComVet Overview of Veterinary Services in Europe (Eurostat Baseline Dataset) ·
- European Parliament and Council Regulation (EU) 2016/429 (EU Animal Health Law)
Claight analysis of public industry data.